Economy

BioMarin Pharmaceutical Inc. (BMRN) Position Increased by Seven Eight Capital LP

(NASDAQ:BMRN) by 20.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,298 shares of the biotechnology company's stock after acquiring an additional 5,002 shares during the quarter. Aperio Group has an ownership of 56,491 stocks of the biotechnology firms shares valued $5,131,000 following acquiring an extra 5,006 shares through out the previous quarter, Emory University lifted its holdings in BioMarin Pharmaceutical by 3.2% through out the 1st period.

Several other institutional investors have also recently bought and sold shares of BMRN. Primecap Management Co. CA lifted its position in BioMarin Pharmaceutical by 10.5% during the 1st quarter. Parallel Advisors LLC now owns 1,042 shares of the biotechnology company's stock valued at $100,000 after buying an additional 125 shares during the period. The Bermuda-based Btg Pactual Global Asset Management Ltd has invested 8.44% in the stock. LLC grew its stake in shares of BioMarin Pharmaceutical by 59.7% in the 1st quarter. Korea Investment CORP grew its stake in shares of BioMarin Pharmaceutical by 143.5% in the 2nd quarter. Ltd. now owns 74,103 shares of the company's stock valued at $6,856,000 after buying an additional 16,012 shares during the last quarter. Finally, Vanguard Group Inc. lifted its position in BioMarin Pharmaceutical by 4.7% during the 2nd quarter. Primecap Management Co. CA now owns 8,712,268 shares of the biotechnology company's stock worth $764,763,000 after acquiring an additional 826,320 shares during the last quarter.

BioMarin Pharmaceutical Inc., launched on October 25, 1996, is a biotechnology company. (NASDAQ:BMRN) were released by: Investorplace.com and their article: "3 Big Stock Charts for Wednesday: Twilio Inc (TWLO), BioMarin Pharmaceutical ..." published on August 23, 2017 as well as Zacks.com's news article titled: "BioMarin (BMRN) Up 2.5% Since Earnings Report: Can It Continue?" with publication date: September 07, 2017. If you are viewing this story on another domain, it was copied illegally and republished in violation of United States and global copyright laws. The correct version of this piece of content can be read at https://weekherald.com/2017/09/19/zurcher-kantonalbank-zurich-cantonalbank-sells-1628-shares-of-biomarin-pharmaceutical-inc-bmrn.html. The stock of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) shares saw heavy trading volume with 1,213K shares changing hands in the last trading session. BioMarin Pharmaceutical has a 52 week low of $78.42 and a 52 week high of $101.27. BioMarin Pharmaceutical Inc. The firm has a 50 day moving average of $86.72 and a 200 day moving average of $89.48.

BioMarin Pharmaceutical (NASDAQ:BMRN) last issued its earnings results on Wednesday, August 2nd.

As of the last earnings report the EPS was $-1.07 and is projected to be $-0.71 for the current year with 175,268,000 shares outstanding. BioMarin Pharmaceutical had 62 analyst reports since August 5, 2015 according to SRatingsIntel. The business had revenue of $317.50 million for the quarter, compared to analysts' expectations of $311.41 million. During the same quarter in the previous year, the firm earned ($2.61) earnings per share. The company's revenue for the quarter was up 5.8% on a year-over-year basis. The Ohio-based Victory Capital Mngmt Inc has invested 0.3% in BioMarin Pharmaceutical Inc.

In other news, SVP Brian Mueller sold 2,671 shares of the firm's stock in a transaction on Thursday, June 22nd. (NASDAQ:BMRN) shares with value of $655,377 were sold by BIENAIME JEAN JACQUES. Following the completion of the transaction, the senior vice president now directly owns 15,556 shares of the company's stock, valued at $1,555,600. The transaction was disclosed in a filing with the SEC, which is available at the SEC website.

In other news, EVP George Eric Davis sold 9,844 shares of the company's stock in a transaction that occurred on Friday, June 23rd. The shares were sold at an average price of $90.50, for a total transaction of $1,357,500.00. Following the transaction, the chief executive officer now owns 174,682 shares in the company, valued at $14,603,415.20. The disclosure for this sale can be found here. Two financial stock experts recommended the company shares with a sell recommendation, around ten have issued a hold recommendation and fifteen have issued a buy recommendation to the share. Insiders own 2.50% of the company's stock.

A number of brokerages have recently commented on BMRN. Sanford C. Bernstein assumed coverage on shares of BioMarin Pharmaceutical in a research note on Thursday, July 27th. The firm issued an overweight rating and a $113.00 price objective on the biotechnology company's stock. Evercore ISI started coverage on shares of BioMarin Pharmaceutical in a report on Wednesday, August 16th. Royal Bank of Canada began coverage on BioMarin Pharmaceutical in a research report on Thursday, September 14th. They set an outperform rating and a $100.00 price objective on the stock. SunTrust Banks, Inc. restated a "buy" rating and issued a $115.00 price objective on shares of BioMarin Pharmaceutical in a report on Friday, July 14th. Barclays Capital has "Equal-Weight" rating and $105 target. BioMarin Pharmaceutical presently has an average rating of Hold and a consensus target price of $109.09. Swiss National Bank lifted its holdings in BioMarin Pharmaceutical by 3.6% through out the 2nd period.

ZIOPHARM Oncology, Inc.is a biopharmaceutical company, which is seeking to develop, acquire and commercialize, on its own or with partners, a portfolio of cancer therapies that address unmet medical needs. The Company's product portfolio consists of approximately five approved products, and multiple clinical and pre-clinical product candidates.



Like this

loading...
loading...

Latest


21 September 2017
Acadian Asset Management LLC Acquires 1879688 Shares of Cisco Systems, Inc. (CSCO)
It is positive, as 81 investors sold CSCO shares while 635 reduced holdings. 117 funds opened positions while 651 raised stakes. Citigroup Inc increased its stake in Cynosure Inc (CYNO) by 172.2% based on its latest 2016Q4 regulatory filing with the SEC.

21 September 2017
Catch up on last night's Emmy Awards with these 5 graphics
He said: "The big winners last night were Donald Glover , Hulu and former White House press secretary Sean Spicer ". However, President Trump aired his feelings on the show while slamming what he perceived as bad ratings.

21 September 2017
Revamped Khelo India to focus on all round development
Asked about the impending Sports Code and efforts to bring sports in the Concurrent list, Rathore said he was taking a "step by step" approach.

21 September 2017
A technical issue has delayed Dontnod's undead RPG Vampyr
Jonathan Reid, a surgeon who returns to London after serving in the Great War, only to be turned into a vampire against his will. Will you embrace the monster within? In your way: vampires of a variety of kinds, vampire hunters, and other monstrosities.

21 September 2017
Pat Neshek says Zack Greinke backed out on autograph promise
If Greinke said he would and then didn't, I can see why it would irk a collector. Now, there's a story about aggressive baseball players doing it on the field.

21 September 2017
Ali Fazal's Victoria & Abdul Releases In The UK, Gets A Thumbs Up
She is one of the most attractive women I have ever laid my eyes on. "I learnt a lot from her". The movie has been directed by Stephen Frears and has been distributed by Focus Features.

21 September 2017
1 quake reported off Japan's east coast
The Japanese quake struck along a major fault line under the Pacific Ocean about 200 miles east of Fukushima. The tremor is said to have measured above 6.1, according to the US Geographical Society (USGS).

21 September 2017
Titans sign receiver Zach Pascal, put LB Aaron Wallace on IR
Seaton replaces offensive lineman Tyler Marz, who was signed off the Titans' practice squad by the Los Angeles Chargers. The Maryland native left ODU as the all-time leading receiver with 233 receptions for 3,193 yards and 30 touchdowns.

21 September 2017
Bama prepares for an unbeaten Vandy
When Alabama comes to town this Saturday, it will be one of the biggest games Vanderbilt has hosted in a long time. Vanderbilt has been very impressive throughout three games, especially on the defensive side of the ball.

21 September 2017
Pence Blasts UN Human Rights Council In Speech To General Assembly
Pence pointed to the systematic attacks by Burma's security forces against minority Rohingya Muslims. Adam Shaw is a Breitbart News politics and United Nations reporter based in NY .